Abstract
Matthew Herder suggests it may be time to re-examine the purpose of the U.S. Orphan Drug Act.
MeSH terms
-
Drug Approval* / economics
-
Drug Approval* / legislation & jurisprudence
-
Humans
-
Orphan Drug Production* / economics
-
Orphan Drug Production* / legislation & jurisprudence
-
Rare Diseases / diet therapy*
-
United States
-
United States Food and Drug Administration*
Grants and funding
MH is currently the Principal Investigator of Grant #EOG 123678 funded by the Canadian Institutes of Health Research entitled “Emerging Health Researchers and the Commercialization of Academic Science.” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.